T +1 202 729 2425
T +86 21 6132 5900
Mr. Ying is a member in White & Case's Global Competition Practice Group. His practice focuses on antitrust investigations and litigation, merger clearance and other commercial litigation matters. Mr. Ying represents clients in investigations by various antitrust agencies, including experience before the Department of Justice, the Federal Trade Commission and state agencies. He is also involved in cases in both federal and state courts.
Mr. Ying has experience with Chinese antitrust issues. He is also serving as a special writer for a Chinese national newspaper on the topic of Chinese antitrust and security enforcement developments.
In addition to his legal education in the U.S., Mr. Ying obtained his civil law degree from a top Japanese college. Mr. Ying was a summer associate in our Tokyo office during his first summer at law school, and he spent the second summer with our Washington office. Mr. Ying is also a native speaker of Mandarin and Shanghainese. Prior to joining the Firm, Mr. Ying worked at a Magic Circle law firm's Shanghai office as a Chinese Legal Consultant for two years. Mr. Ying is also committed to serving pro bono clients on behalf of the Firm, and he has been involved in various matters.
Representing a major Japanese auto parts manufacture in DOJ criminal antitrust and follow-up civil litigation.
Representing a leading Chinese telecommunication manufacture in a complaint against a US telecommunication company for unlawful monopolization.
Advised a national pharmaceutical company regarding a subpoena filed by the New York Attorney General.
Represented a top U.S. home construction company in civil antitrust litigation.
Represented an executive of a leading Japanese auto parts manufacturer in a DOJ cartel investigation.
Defended a multinational airline company in an investigation of alleged market allocation and price fixing.
Advised Hepalink, one of the largest Chinese pharmaceutical companies, in its $337.5 Million acquisition of Scientific Protein Laboratories, LLC, a leading U.S. active pharmaceutical ingredients (APIs) manufacturer.
Prepared a Chinese merger filing on behalf of Midea Group in its joint venture with Electrolux Group.
Advised Anthem Inc. in its acquisition of Cigna Corp. before the FTC and the DOJ.
Represented Toyota Industries Corporation, a top Japanese lift truck manufacturer, in its $760 million acquisition of Cascade, the largest U.S. lift truck attachments manufacturer.
Represented a top U.S. food service company in a multi-billion merger deal.
Advising a Chinese company regarding a potential violation of US sanction regulations and follow-up legal compliance.
Represented an international bank regarding an investigation conducted by the U.S. Securities and Exchange Commission.
Advised a multinational company regarding an investigation prompted by a Chinese authority in charge of general trade issues.
Presenter, "Introduction to U.S. Antitrust Law" (in Mandarin), The Shanghai Bar Association, 11 September 2014, Shanghai, China
Speaker, "The Impact of China's Newly Introduced Labor Contract Law on Foreign Investors" (in Japanese), The Japanese Institute of International Business Law, Inc., 31 July 2007, Tokyo, Japan
"Blocked Shipping Alliance Reveals Modest Improvement in Chinese Antitrust Review Transparency," Washington Legal Foundation Legal Backgrounder, August 22, 2014 (with Noah Brumfield)
"A Look at 1st M&A Deals Under China's New Review Process," Law360, August 8, 2014 (with Noah Brumfield, Alex Zhang and Lucy Xu)
"What To Expect From China's Antitrust Consolidation," Law360, April 5, 2018 (with Noah Brumfield, J. Mark Gidley and Alex Zhang)